Glyxambi combines two antihyperglycaemic medicinal products with complementary mechanisms of action to improve glycaemic control in patients with type 2 ...SkiptomaincontentGlyxambi25mg/5mgFilm-coatedTabletsBacktotopBoehringerIngelheimLimitedcontactdetailsActiveingredientlinagliptinempagliflozinLegalCategoryPOM:PrescriptiononlymedicineATCcodeA10BD19FindsimilarproductsReportSideEffectRelatedMedicinesSameactiveingredientsSamecompanyBookmarkEmailLastupdatedonemc:09Sep2021ViewchangesPrintShowtableofcontentsHidetableofcontents1.Nameofthemedicinalproduct2.Qualitativeandquantitativecomposition3.Pharmaceuticalform4.Clinicalparticulars4.1Therapeuticindications4.2Posologyandmethodofadministration4.3Contraindications4.4Specialwarningsandprecautionsforuse4.5Interactionwithothermedicinalproductsandotherformsofinteraction4.6Fertility,pregnancyandlactation4.7Effectsonabilitytodriveandusemachines4.8Undesirableeffects4.9Overdose5.Pharmacologicalproperties5.1Pharmacodynamicproperties5.2Pharmacokineticproperties5.3Preclinicalsafetydata6.Pharmaceuticalparticulars6.1Listofexcipients6.2Incompatibilities6.3Shelflife6.4Specialprecautionsforstorage6.5Natureandcontentsofcontainer6.6Specialprecautionsfordisposalandotherhandling7.Marketingauthorisationholder8.Marketingauthorisationnumber(s)9.Dateoffirstauthorisation/renewaloftheauthorisation10.DateofrevisionofthetextThisinformationisintendedforusebyhealthprofessionals Thismedicinalproductissubjecttoadditionalmonitoring.Thiswillallowquickidentificationofnewsafetyinformation.Healthcareprofessionalsareaskedtoreportanysuspectedadversereactions.Seesection4.8forhowtoreportadversereactions.1.NameofthemedicinalproductGlyxambi10mg/5mgfilm-coatedtabletsGlyxambi25mg/5mgfilm-coatedtablets2.QualitativeandquantitativecompositionGlyxambi10mg/5mgfilm-coatedtabletsEachfilm-coatedtabletcontains10mgempagliflozinand5mglinagliptin.Glyxambi25mg/5mgfilm-coatedtabletsEachfilm-coatedtabletcontains25mgempagliflozinand5mglinagliptin.Forthefulllistofexcipients,seesection